The impact of COVID-19 on endoscopy and cancer screening: a focus on access and equity.

IF 4.2 3区医学

Therapeutic Advances in Gastroenterology Pub Date : 2023-01-01 DOI:10.1177/17562848231173334

Julianna G Gardner, Lauren D Feld

引用次数: 0

Abstract

The SARS-CoV2 pandemic has had a profound and lasting impact on healthcare delivery. Gastrointestinal endoscopy services were limited during the early phases of the pandemic, which has resulted in ongoing procedural backlog. Procedural delays have had continuing effects including delayed colorectal cancer (CRC) diagnoses and exacerbation of existing disparities in the CRC-screening and treatment pathways. In this review, we outline these effects as well as the variety of strategies that have been proposed to eliminate this backlog, including increased endoscopy hours, re-triaging of referrals, and alternative CRC-screening strategies.

Abstract Image

查看原文本刊更多论文

COVID-19对内窥镜检查和癌症筛查的影响:关注可及性和公平性。

SARS-CoV2大流行对卫生保健服务产生了深远而持久的影响。在大流行的早期阶段，胃肠内窥镜检查服务有限，导致程序性积压。程序上的延迟已经产生了持续的影响，包括结直肠癌(CRC)诊断的延迟以及CRC筛查和治疗途径中现有差异的加剧。在这篇综述中，我们概述了这些影响以及各种已经提出的消除积压的策略，包括增加内窥镜检查时间，重新分类转诊和替代crc筛查策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Advances in Gastroenterology Medicine-Gastroenterology

自引率

2.40%

发文量

103

期刊介绍： Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.